The agreement was never formally extended, but NDC has continued paying $5.5 million annually, a price unadjusted since execution
The world of weight loss has been transformed by the arrival of glucagon-like peptide-1 (GLP-1) agonists (e.g
Federal courts have consolidated cases involving these GLP-1 receptor agonist medications: Wegovy (semaglutide): Manufactured by Novo Nordisk and approved by the FDA in June 2021 specifically for chronic weight management in adults with obesity or who are overweight with at least one weight-related condition
Another new partner, CDR-Life Inc., which is likewise headquartered in Switzerland, also focuses on the latter indication
Please consult your veterinarian if you have any questions
Whether you and your surgeon agree on general anesthesia or twilight sedation, our qualified anesthesiologists and surgical team will monitor you closely for safety and peace of mind